<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Ferrara, Francesca</dc:creator>
  <dc:creator>Molesti, Eleonora</dc:creator>
  <dc:creator>Böttcher-Friebertshäuser, Eva</dc:creator>
  <dc:creator>Cattoli, Giovanni</dc:creator>
  <dc:creator>Corti, Davide</dc:creator>
  <dc:creator>Scott, Simon D.</dc:creator>
  <dc:creator>Temperton, Nigel J.</dc:creator>
  <dc:date>2013-02-20</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The monomer of influenza haemagglutinin is synthesized as a single polypeptide precursor that during  maturation is cleaved by proteases into two active subunits. Other studies have demonstrated that the  human Transmembrane Protease Serine 2 (TMPRSS2) can cleave the HA of human seasonal  influenza viruses. Consequently, we have investigated the use of human Transmembrane Protease  Serine 2 to produce high titre influenza haemmagglutinin (HA) lentiviral pseudotypes from Group 2  influenza viruses. Such pseudotypes represent powerful and safe tools to study viral entry and  immune responses. Influenza pseudotype particles are obtained by co- transfecting human embryonic  kidney HEK293T/17 cells using plasmids coding for the influenza HA, HIV gag-pol and a lentiviral  vector incorporating firefly luciferase. However, in order to produce Group 2 pseudotypes, it was  necessary to co-transfect a plasmid expressing the TMPRSS2 endoprotease, to achieve the  necessary HA cleavage for infective particle generation. These lentiviral pseudotypes were shown to  transduce HEK293T/17 cells with high efficiency. This demonstrates that TMPRSS2 is necessary for  the functional activation, in vitro, of both the HA of human seasonal influenza and other Group 2 HA  influenza strains. Additionally, we show that the Group 2 influenza pseudotype particles can be used  as surrogate antigens in neutralization assays and are efficiently neutralized by corresponding  influenza virus reference sera. These data demonstrate that the viral pseudotype system is a powerful  method for serological surveillance of a wide range of influenza viruses.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1318868</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/318868</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318868/files/Ferrara_JMGM_2013.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.4172/1747-0862.1000055</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318868</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY-NC</dc:rights>
  <dc:source>Journal of molecular and genetic medicine. - 2013, vol. 7, p. 309-314</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Haemagglutinin</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Protease cleavage</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Antibody response</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Pseudotype serology</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">The human transmembrane protease serine 2 is necessary for the production of group 2 influenza A virus pseudotypes</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
